![Béatrice de Vos](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Béatrice de Vos
Chief Tech/Sci/R&D Officer at EUROPEAN MEDICAL SOLUTIONS
Béatrice de Vos active positions
Companies | Position | Start | End |
---|---|---|---|
EUROPEAN MEDICAL SOLUTIONS | Chief Tech/Sci/R&D Officer | - | - |
Belgian College of Pharmaceutical Medicin | Corporate Officer/Principal | - | - |
Career history of Béatrice de Vos
Former positions of Béatrice de Vos
Companies | Position | Start | End |
---|---|---|---|
EUROPEAN MEDICAL SOLUTIONS | Chairman | 12/06/2013 | 19/03/2017 |
Independent Dir/Board Member | 12/06/2013 | 19/03/2017 | |
PROMETHERA Biosciences SA
![]() PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Chief Tech/Sci/R&D Officer | 31/12/2010 | 31/03/2015 |
Sanofi Pasteur
![]() Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Chief Tech/Sci/R&D Officer | 31/12/2006 | 31/12/2009 |
GlaxoSmithKline Biologicals NV
![]() GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Chief Tech/Sci/R&D Officer | 31/12/1998 | 31/12/2006 |
Wyeth-Ayerst Research | Corporate Officer/Principal | 31/12/1991 | 31/12/1998 |
Training of Béatrice de Vos
University of Antwerp | Doctorate Degree |
Statistics
International
Belgium | 6 |
France | 2 |
United States | 2 |
Operational
Chief Tech/Sci/R&D Officer | 4 |
Corporate Officer/Principal | 2 |
Chairman | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
EUROPEAN MEDICAL SOLUTIONS | Health Technology |
Private companies | 4 |
---|---|
GlaxoSmithKline Biologicals NV
![]() GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Health Technology |
Sanofi Pasteur
![]() Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Health Technology |
Wyeth-Ayerst Research | |
PROMETHERA Biosciences SA
![]() PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Health Technology |
- Stock Market
- Insiders
- Béatrice de Vos
- Experience